Therefore, accurately predicting the Ki-67 expression level in IDH-wildtype glioblastoma is clinically significant, as it helps to assess the biological behavior of the tumor and provides assistance in making patient treatment strategies. This evidence concerns the gene MKI67 and glioblastoma.